Kennedy Lewis Management’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Kennedy Lewis Management’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$17K	–	8
2024 Q1	$17K	Buy	+50,000	New	+$14.2K	0.07%	4
2023 Q3	–	Sell	-50,000	Closed	-$7.71K	–	9
2023 Q2	$7.71K	Hold	50,000	–	–	0.03%	7
2023 Q1	$4.89K	Hold	50,000	–	–	0.01%	11
2022 Q4	$3K	Hold	50,000	–	–	﹤0.01%	10
2022 Q3	$4K	Hold	50,000	–	–	﹤0.01%	13
2022 Q2	$14K	Hold	50,000	–	–	0.02%	11
2022 Q1	$20K	Hold	50,000	–	–	0.01%	16
2021 Q4	$33K	Buy	+50,000	New	+$33.5K	0.02%	24

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Kennedy Lewis Management's AONCW Position: Q2 2024 in Review

Kennedy Lewis Management sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 50,000 shares — an estimated $17K sold.

Kennedy Lewis Management first reported a position in AONCW in Q4 2021 and held it in 8 quarters. The position peaked at $33K in Q4 2021. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

Kennedy Lewis Management reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
Kennedy Lewis Management sold 50,000 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $17K.
Kennedy Lewis Management first reported a position in American Oncology Network, Inc. Warrant in Q4 2021 and held it in 8 quarters.
Kennedy Lewis Management's American Oncology Network, Inc. Warrant position peaked at $33K in Q4 2021.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on Kennedy Lewis Management's 13F filing for Q2 2024, filed 13 Aug 2024.